Tag: FIN HEA BIO MTC PHA CPR

Enliven Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

BOULDER, Colo., June 13, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsFIN HEA BIO MTC PHA CPR

Alvopetro Announces June 2025 Sales Volumes

Oxford Business Group and Oman Investment Authority highlight sultanate’s economic transformation in new advisory report

Iridium Announces Release Date for Second-Quarter 2025 Financial Results

Tag: FIN HEA BIO MTC PHA CPR

Enliven Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us